Although there is some support for an association between duration of exposure and cumulative dose of prolactin-increasing antipsychotics and breast cancer, with limited suggestion of a possible dose-response relationship,26 evidence that this association may be mediated by hyperprolactinemia and its amplitude is still lacking. The gene discussed is PRL; the disease is breast cancer.